图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
医药载体系统评论综述
影响因子: 2.9 5年影响因子: 3.72 SJR: 0.736 SNIP: 0.551 CiteScore™: 2.43

ISSN 打印: 0743-4863
ISSN 在线: 2162-660X

医药载体系统评论综述

DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i5.30
24 pages

Transcutaneous Immunization: An Emerging Route of Immunization and Potent Immunostimulation Strategy

Scott A. Hammond
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Mimi Guebre-Xabier
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Jianmei Yu
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878
Gregory M. Glenn
IOMAI Corporation, 20 Firstfield Rd., Suite 250, Gaithersburg MD 20878

ABSTRACT

Transcutaneous immunization (TCI) has emerged recently as a new method of vaccination that uses the skin. The simplicity of a patch-based immunization may obscure the potency of this strategy for immunostimulation because TCI allows the safe use of a wide variety of potent adjuvants. It is thought that these adjuvants activate Langerhans cells in the skin, which migrate to the draining lymph to orchestrate robust systemic immune responses. TCI represents a novel combination using established knowledge relating to skin penetration, the potency of adjuvant-based immunostimulation, and data showing that Langerhans cells are highly desirable targets because of their antigen-presenting cell function. The near-term challenge will be to take this promising insight into successful product development.